Cortellini A, Barrichello APC, Alessi JV, Ricciuti B, et al. A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions. Ann Oncol 2022;33:1202-1204.
PMID: 35953005